210 related articles for article (PubMed ID: 14628197)
1. Microprolactinomas in males treated by transsphenoidal surgery.
Wolfsberger S; Czech T; Vierhapper H; Benavente R; Knosp E
Acta Neurochir (Wien); 2003 Nov; 145(11):935-40; discussion 940-1. PubMed ID: 14628197
[TBL] [Abstract][Full Text] [Related]
2. Use of the Leksell gamma knife in the treatment of prolactinoma patients.
Jezková J; Hána V; Krsek M; Weiss V; Vladyka V; Liscák R; Vymazal J; Pecen L; Marek J
Clin Endocrinol (Oxf); 2009 May; 70(5):732-41. PubMed ID: 18710463
[TBL] [Abstract][Full Text] [Related]
3. Surgery, dopamine agonist therapy of combined treatment--results in prolactinoma patients after a 12 month follow-up.
Hildebrandt G; Bauer T; Stracke H; Fassbender WJ; Mueller HW; Agnoli AL; Federlin K; Roosen K
Zentralbl Neurochir; 1992; 53(3):123-34. PubMed ID: 1414079
[TBL] [Abstract][Full Text] [Related]
4. Endocrinological outcome following first time transsphenoidal surgery for GH-, ACTH-, and PRL-secreting pituitary adenomas.
Kristof RA; Schramm J; Redel L; Neuloh G; Wichers M; Klingmüller D
Acta Neurochir (Wien); 2002 Jun; 144(6):555-61; discussion 561. PubMed ID: 12111488
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of transsphenoidal surgery in prolactinomas: improvement of hormonal control in dopamine agonist-resistant patients.
Primeau V; Raftopoulos C; Maiter D
Eur J Endocrinol; 2012 May; 166(5):779-86. PubMed ID: 22301915
[TBL] [Abstract][Full Text] [Related]
6. Clinical and histological correlations in prolactinomas, with special reference to bromocriptine resistance.
Delgrange E; Sassolas G; Perrin G; Jan M; Trouillas J
Acta Neurochir (Wien); 2005 Jul; 147(7):751-7; discussion 757-8. PubMed ID: 15971099
[TBL] [Abstract][Full Text] [Related]
7. [Transsphenoidal microsurgical results of non-invasive prolactinomas].
Xu ZQ; Su CB; Ren ZY; Wang RZ; Yang Y; Ma WB; Li YN; Xing B; Lian W; Yang Z
Zhonghua Wai Ke Za Zhi; 2008 Feb; 46(4):293-5. PubMed ID: 18683769
[TBL] [Abstract][Full Text] [Related]
8. Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma.
Karavitaki N; Thanabalasingham G; Shore HC; Trifanescu R; Ansorge O; Meston N; Turner HE; Wass JA
Clin Endocrinol (Oxf); 2006 Oct; 65(4):524-9. PubMed ID: 16984247
[TBL] [Abstract][Full Text] [Related]
9. [Prolactin microadenoma in men. Study of 14 cases].
Gimenez-Roqueplo AP; Dupuy M; Delalande O; Visot A; Jedynak CP; Peillon F; Derome PJ
Ann Med Interne (Paris); 1992; 143(2):94-7. PubMed ID: 1530227
[TBL] [Abstract][Full Text] [Related]
10. [Transsphenoidal approach to prolactinomas].
López-Arbolay O; Morales-Sabina O; González-González JL; Valdés-Lorenzo N
Neurocirugia (Astur); 2006 Jun; 17(3):226-31. PubMed ID: 16855780
[TBL] [Abstract][Full Text] [Related]
11. [Results of treatment for male prolactinomas].
Iwai Y; Yamanaka K; Ishiguro T; Morikawa T; Matsuzaka Y; Komiyama M; Yasui T
No Shinkei Geka; 2002 Dec; 30(12):1285-92. PubMed ID: 12491580
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome of patients with macroprolactinomas initially treated with dopamine agonists.
Kars M; Pereira AM; Smit JW; Romijn JA
Eur J Intern Med; 2009 Jul; 20(4):387-93. PubMed ID: 19524180
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of serum prolactin levels measured immediately after transsphenoidal surgery.
Amar AP; Couldwell WT; Chen JC; Weiss MH
J Neurosurg; 2002 Aug; 97(2):307-14. PubMed ID: 12186458
[TBL] [Abstract][Full Text] [Related]
14. The outcome of hypophysectomy for prolactinomas in the era of dopamine agonist therapy.
Soule SG; Farhi J; Conway GS; Jacobs HS; Powell M
Clin Endocrinol (Oxf); 1996 Jun; 44(6):711-6. PubMed ID: 8759184
[TBL] [Abstract][Full Text] [Related]
15. Prolactinomas: Prognostic Factors of Early Remission After Transsphenoidal Surgery.
Zielinski G; Ozdarski M; Maksymowicz M; Szamotulska K; Witek P
Front Endocrinol (Lausanne); 2020; 11():439. PubMed ID: 32733387
[No Abstract] [Full Text] [Related]
16. Endoscopic endonasal transsphenoidal surgery for invasive pituitary adenoma.
Zhang X; Fei Z; Zhang W; Zhang JN; Liu WP; Fu LA; Cao WD; Jiang XF; Song SJ
J Clin Neurosci; 2008 Mar; 15(3):241-5. PubMed ID: 18207408
[TBL] [Abstract][Full Text] [Related]
17. Gamma knife radiosurgery for medically and surgically refractory prolactinomas.
Pouratian N; Sheehan J; Jagannathan J; Laws ER; Steiner L; Vance ML
Neurosurgery; 2006 Aug; 59(2):255-66; discussion 255-66. PubMed ID: 16883166
[TBL] [Abstract][Full Text] [Related]
18. Transsphenoidal microsurgical results of female patients with prolactinomas.
Ikeda H; Watanabe K; Tominaga T; Yoshimoto T
Clin Neurol Neurosurg; 2013 Sep; 115(9):1621-5. PubMed ID: 23498159
[TBL] [Abstract][Full Text] [Related]
19. Microsurgical management of prolactinomas - clinical and hormonal outcome in a series of 172 cases.
Sinha S; Sharma BS; Mahapatra AK
Neurol India; 2011; 59(4):532-6. PubMed ID: 21891928
[TBL] [Abstract][Full Text] [Related]
20. [Pregnancy in hyperprolactinemic patients].
Ventz M; Puhlmann B; Knappe G; Gerl H; Lehmann R; Rohde W
Zentralbl Gynakol; 1996; 118(11):610-5. PubMed ID: 9082694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
